Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3027529	s-toxoabm	— (—)	4853	5977	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other bacterial diseases

1397

2725

3.30

316.76

1.2

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1944

2412

5.38

307.65

1.3

1.2

—

First line medication for Crohn's disease

1754

2466

3.91

307.65

1.2

—

Failure and rejection of transplanted organs and tissues

214

82.76

307.65

1.5

1.2

—

Renal tubulo-interstitial diseases

1468

2722

4.10

307.65

1.2

1.3

—

Persons encountering health services for specific procedures and health care

1731

2828

3.74

307.65

1.2

—

Dialysis

450

105

60.20

307.65

1.2

—

Other dialysis

352

54.07

307.65

1.2

—

ILD medications

1928

2425

4.40

307.65

1.2

—

Preparatory care for dialysis

398

119

44.06

307.65

1.1

1.2

—

Dialysis, with operation codes

1126

309

45.80

307.65

1.1

1.2

—

Myeloid leukaemia

211

39.00

307.65

1.4

1.2

—

Transplanted organ and tissue status

1572

218

115.92

307.65

1.3

1.2

—

ILD medications: prednisolone, methylprednisolone, prednisone

1832

2372

4.41

307.65

1.2

—

Septicaemia

685

1045

6.29

307.65

1.3

1.2

—

Chronic kidney disease

1085

573

19.95

307.65

1.1

1.2

—

Heart failure, not strict

1308

1418

6.44

307.65

1.2

—

Extracorporeal dialysis

581

189

40.54

307.65

1.1

1.2

—

Care involving dialysis

824

185

59.15

307.65

1.1

1.2

—

L04AA Selective immunosuppressants

1274

741

19.43

307.65

1.2

—

Bacterial infection, other or unspecified

964

1467

5.70

307.65

1.2

—

L04AD Calcineurin inhibitors

1416

310

65.82

307.65

1.2

—

Glomerular disorders in diseases classified elsewhere

494

368

14.81

307.65

1.1

1.2

—

All chronic kidney diseases

1240

1325

7.94

307.65

1.2

—

Fever of other and unknown origin

1047

1919

4.98

307.65

1.2

—

Nephropathy related operations

1153

311

47.66

307.65

1.1

1.2

—

Acute renal failure

445

433

10.71

307.65

1.2

—

Caries of dentine

656

735

9.14

307.65

1.2

—

Primary_lymphoid and hematopoietic malignant neoplasms

771

574

14.37

307.65

1.3

1.2

—

Explicit Sepsis

720

1286

5.36

307.65

1.3

1.2

—

Dental caries

756

843

9.07

307.65

1.2

—

Donors of organs and tissues

217

71.86

307.65

1.6

1.3

—

Bacterial infection, other or unspecified

931

1323

6.27

307.65

1.2

—

Secondary hypertension

454

164

31.05

307.65

1.1

1.3

—

Liquid cancers, helper endpoint

895

850

9.58

307.65

1.3

1.1

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1516

2809

3.79

307.65

1.2

—

Kidney transplant status

925

179

93.42

307.65

1.1

1.2

—

ILD medications: immunosuppressive drugs

1842

1967

9.10

307.65

1.2

—

Renal failure

1234

909

12.61

307.65

1.2

—

Glomerular diseases

650

604

11.61

307.65

1.2

—

Disorders resulting from impaired renal tubular function

277

101

34.23

307.65

1.1

1.2

—

Other septicaemia

633

922

6.79

307.65

1.3

1.2

—

All kidney diseases

1571

3000

3.65

307.65

1.2

1.3

—

Other bacterial diseases

1364

2447

3.81

307.65

1.2

—

Other/unspecified cytomegaloviral diseases

196

39.60

304.76

1.2

—

Cytomegalovirus infection, IBD co-morbidity

204

33.85

304.41

1.2

—

Enlarged lymph nodes

401

504

8.33

298.75

1.2

1.3

—

Cytomegaloviral disease

205

30.84

296.82

1.2

—

Bacterial Sepsis

642

1086

5.16

287.73

1.2

—

Aplastic and other anaemias

638

1206

5.04

287.02

1.2

—

Implicit bacterial Sepsis

564

893

5.72

286.29

1.2

—

Other disorders of kidney and ureter

342

380

9.53

281.96

1.1

1.2

—

Cystic kidney disease

210

113

22.23

272.10

1.1

1.2

—

Implicit bacterial Sepsis

590

995

5.23

269.46

1.2

—

Acute myeloid leukaemia and myelodysplastic syndromes

148

67.36

267.02

1.4

1.2

—

Non-Hodgkin lymphoma, all, including Hilmo

279

251

11.63

266.86

1.3

1.2

—

Cystic kidney disease

212

123

20.33

264.77

1.1

1.2

—

Polycystic kidney disease

192

100

23.56

253.20

1.1

1.2

—

Viral Sepsis

388

570

7.05

251.37

1.2

—

Implicit viral Sepsis

386

568

7.04

249.69

1.2

—

Unspecified kidney failure

225

163

14.49

246.06

1.1

1.2

—

Implicit viral Sepsis

460

844

5.59

237.65

1.2

—

Glomerulonephritis

304

363

8.95

237.38

1.1

1.2

—

Hypertensive diseases (excluding secondary)

780

1110

4.16

234.58

1.2

1.3

—

Congenital malformations of the urinary system

253

250

11.22

229.35

1.1

1.2

—

Congenital malformations of the urinary system

257

261

10.85

228.26

1.1

1.2

—

Infections, IBD-co-morbidities

398

412

7.16

224.95

1.3

1.2

—

Anaemias

564

747

5.09

222.27

1.2

1.3

—

Other diseases of blood and blood-forming organs, wide

415

742

5.79

221.17

1.3

1.2

—

Implicit Sepsis

894

2048

3.34

218.46

1.2

—

Heart failure and antihypertensive medication

416

427

6.55

209.85

1.2

1.3

—

Acute myeloid leukaemia, helper endpoint

112

87.52

208.81

1.4

1.3

—

Acute myeloid leukaemia, including Hilmo

112

87.52

208.81

1.4

1.3

—

Acute myeloid leukaemia

112

87.52

208.81

1.4

1.3

—

Diabetic nephropathy

336

520

6.68

204.29

1.2

—

Covid-19 confirmed case

561

1400

4.10

199.19

1.2

—

Any gastric operation

1003

1601

3.18

198.19

1.2

1.3

—

GASTRO-related operations

1003

1601

3.18

198.19

1.2

1.3

—

Diabetic nephropathy, excluding more controls

335

412

7.02

197.48

1.2

—

ILD medications: azathioprine

305

451

7.02

196.64

1.2

1.3

—

Other and unspecified anaemias

500

1094

4.43

194.93

1.2

—

Lung transplantation

116

59.06

192.99

1.1

1.2

—

Other anaemias

502

1107

4.39

192.98

1.2

—

Lung transplant status

115

60.29

192.42

1.1

1.2

—

Hypertensive diseases

955

1756

3.11

190.17

1.2

1.3

—

Implicit Sepsis

940

2329

2.99

190.05

1.2

—

Hypertension

954

1755

3.11

189.76

1.2

1.3

—

General symptoms and signs

1302

2505

2.63

186.61

1.2

—

Other disorders involving the immune mechanism, not elsewhere classified

166

126

15.13

179.24

1.1

1.3

—

Chronic nephritic syndrome

160

113

15.71

179.04

1.1

1.2

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

161

118

15.79

177.55

1.1

1.3

—

Acute peritonitis

193

186

11.13

177.04

1.1

1.2

—

Disorders of parathyroid gland

303

487

6.31

176.86

1.1

1.2

—

Hyperparathyroidism

282

422

6.80

176.71

1.1

1.2

—

Condition for Implicit Sepsis (Organ dysfunction codes)

966

2433

2.84

176.56

1.2

—

IgA nephropathy (IgA glomerulonephritis)

147

18.71

175.99

1.1

1.2

—

Heart failure,strict

512

849

4.32

174.75

1.2

—

Certain infectious and parasitic diseases

1117

2053

2.75

174.04

1.2

—

Provisional assignment of new diseases of uncertain etiology

748

2521

3.01

165.61

1.2

—

Codes for special purposes

748

2526

3.01

165.03

1.2

—

Anaemia in chronic diseases classified elsewhere

121

23.99

163.97

1.1

1.2

—

Secondary and unspecified malignant neoplasm of lymph nodes

183

190

10.12

158.61

1.3

1.2

—

Other heart diseases

628

1205

3.45

154.43

1.2

1.3

—

Non-follicular lymphoma

197

234

8.82

153.96

1.3

1.2

—

Agranulocytosis

237

350

7.08

153.37

1.3

1.2

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

103

29.93

153.24

1.1

1.2

—

Chronic lymphocytic leukaemia, helper endpoint

103

29.93

153.24

1.1

1.2

—

Chronic lymphocytic leukaemia

103

29.93

153.24

1.1

1.2

—

Multiple myeloma, including Hilmo

120

19.17

150.60

1.8

1.1

—

Lymphoid leukaemia

162

154

11.29

150.05

1.2

—

Certain disorders involving the immune mechanism

338

712

4.90

149.77

1.2

—

Influenza and pneumonia

1251

3456

2.33

149.33

1.2

—

Secondary uncertain malignant neoplasm

203

260

8.05

148.60

1.3

1.2

—

Pneumonias (Asthma/COPD co-morbidities)

1158

3299

2.38

147.80

1.2

—

Condition for Implicit Sepsis (Organ dysfunction codes)

987

2704

2.54

145.81

1.2

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1042

2532

2.52

145.54

1.2

—

1042

2532

2.52

145.54

1.2

—

Percutaneous Coronary Intervention

782

1676

2.89

142.24

1.2

—

Coronary revascularization (ANGIO or CABG)

782

1677

2.89

141.75

1.2

—

Gout, FINNGEN

332

717

4.71

141.53

1.2

1.1

—

All pneumoniae

1168

3399

2.32

140.58

1.2

—

Pneumonia, organism unspecified

1022

2968

2.44

139.02

1.2

—

Nephrotic syndrome

133

107

13.87

138.11

1.2

—

Azathioprine

305

634

4.98

137.48

1.2

1.3

—

Emergency coronary revascularization (for ACS)

806

1775

2.79

137.25

1.2

—

Cardiovascular diseases (excluding rheumatic etc)

920

2066

2.59

134.03

1.2

1.3

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

341

764

4.48

133.53

1.2

1.3

—

Other viral diseases

516

1598

3.30

132.29

1.2

1.3

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

345

798

4.34

129.88

1.2

1.3

—

Leukaemia of unspecified cell type

45.71

127.82

1.3

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1103

3344

2.27

127.27

1.2

—

Diseases of peritoneum

204

320

6.64

124.64

1.1

1.2

—

Major coronary heart disease event

783

1783

2.68

123.44

1.2

—

Ischemic heart diseases

786

1793

2.66

122.18

1.2

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1184

2931

2.21

121.41

1.2

—

Gout

332

700

4.25

119.82

1.2

1.1

—

Multiple myeloma and malignant plasma cell neoplasms

119

101

12.55

118.65

1.7

1.2

—

Hypertension, essential

774

1663

2.66

118.31

1.1

1.3

—

Fibrosis and cirrhosis of liver

161

208

8.12

117.50

1.2

—

Factors influencing health status and contact with health services

259

197

6.66

116.61

1.2

1.1

—

Metabolic disorders

964

2530

2.35

116.52

1.2

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

235

450

5.39

116.38

1.2

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

206

349

6.06

116.14

1.3

1.2

—

Myelodysplastic syndrome, including Hilmo

22.61

115.77

1.4

1.2

—

Oesophageal varices

124

118

11.32

114.89

1.2

—

Other viral diseases

602

2194

2.77

114.33

1.2

1.3

—

Cardiovascular diseases

885

1959

2.46

113.55

1.2

1.3

—

Inflammatory bowel disease treatment related agents

1264

3410

2.09

113.48

1.2

—

Persons encountering health services in other circumstances, wide

1212

2933

2.14

113.40

1.2

—

Hernia of abdominal wall, postoperative

181

275

6.69

113.35

1.2

—

Cirrhosis of liver, NAS

130

139

9.93

110.55

1.2

—

Intestinal infectious diseases

1054

3738

2.16

110.49

1.2

—

Non-Hodgkin lymphoma, all

16.52

110.17

1.4

1.1

—

Heart failure, strict

516

1190

3.09

110.07

1.2

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

261

353

5.20

109.41

1.2

1.3

—

Hard cardiovascular diseases

775

1849

2.52

108.59

1.2

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

23.75

108.36

1.8

1.1

—

Multiple myeloma

23.75

108.36

1.8

1.1

—

General examination and investigation of persons without complaint and reported diagnosis

705

1379

2.69

107.56

1.2

—

ILD, hospital admission 2, with pulmonary infections

143

178

8.28

107.27

1.1

1.2

—

Disorders of lens

638

1462

2.75

107.12

1.2

—

Medical observation and evaluation for suspected diseases and conditions

712

1380

2.66

105.68

1.2

—

Coagulation defects, purpura and other haemorrhagic conditions

308

791

4.00

105.62

1.3

1.2

—

Examination and observation for other reasons

646

1375

2.75

105.55

1.2

—

Other disorders of fluid, electrolyte and acid-base balance

318

794

3.87

103.98

1.2

—

Heart failure and coronary heart disease

374

743

3.61

101.34

1.2

—

Dependence on enabling machines and devices, not elsewhere classified

40.57

101.26

1.5

1.1

—

Diseases of liver

405

1287

3.20

99.90

1.2

—

Genitourinary diseases

694

1344

2.62

98.86

1.2

—

Hypertensive Renal Disease

16.09

97.13

1.1

1.2

—

Other medical care

390

1090

3.25

96.88

1.2

—

L04AX Other immunosuppressants

634

2592

2.48

96.51

1.3

1.2

—

Acute tubulo-interstitial nephritis

613

2098

2.55

96.34

1.2

—

Second line medication for Crohn's disease

653

2712

2.44

96.03

1.3

1.2

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

105

101

10.78

95.92

1.2

1.1

—

All-cause Heart Failure

481

1162

2.95

95.06

1.2

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

175

189

6.73

94.32

1.1

1.2

—

Diffuse large B-cell lymphoma, helper endpoint

12.20

93.54

1.3

1.1

—

Diffuse large B-cell lymphoma, including Hilmo

12.20

93.54

1.3

1.1

—

Diffuse large B-cell lymphoma

12.20

93.54

1.3

1.1

—

Other respiratory diseases principally affecting the interstitium

208

433

4.91

93.36

1.1

1.2

—

Insulin, fast-acting

442

1538

2.92

92.91

1.2

—

Rare circulating lymphoid malignancy, including Hilmo

12.41

91.42

1.3

1.2

—

Insulin, fast-acting or short human

444

1576

2.86

89.97

1.2

—

Fungal Sepsis

102

104

10.41

89.83

1.3

1.2

—

Diarrhoea and gastroenteritis of presumed infectious origin

1039

3412

2.02

89.33

1.3

1.2

—

Insulin, combination of fast acting with intermediate-acting or long-acting

618

2345

2.43

89.28

1.2

—

Hepatocellular carcinoma, including Hilmo

17.55

89.01

1.2

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

790

3292

2.18

88.25

1.3

1.2

—

Implicit fungal Sepsis

10.65

87.57

1.2

—

ILD, hospital admissions 1, main diag only

171

318

5.51

87.44

1.1

1.2

—

Autoimmune diseases excluding thyroid diseases

1114

3099

1.98

85.81

1.2

1.3

—

Purpura and other haemorrhagic conditions

216

498

4.46

85.77

1.3

1.2

—

Ascites

126

176

7.42

85.77

1.2

—

Malignant neoplasm of liver and intrahepatic bile ducts

18.15

85.70

1.2

1.1

—

Autoimmune diseases excluding thyroid diseases, strict definition

1093

3037

1.99

85.41

1.2

1.3

—

Presence of cardiac and vascular implants and grafts

292

584

3.75

85.20

1.2

1.1

—

Certain infectious and parasitic diseases

698

1459

2.41

85.09

1.3

1.2

—

ILD, hospital admissions

178

352

5.17

84.93

1.1

1.2

—

Interstitial lung disease

178

354

5.14

84.37

1.1

1.2

—

Other interstitial pulmonary diseases

178

354

5.14

84.37

1.1

1.2

—

Interstitial lung disease endpoints

178

354

5.14

84.37

1.1

1.2

—

Thrombocytopenia, unspecified

141

227

6.48

84.16

1.3

1.2

—

Malignant neoplasm, wide definition for exclusion

837

2281

2.17

83.77

1.3

1.2

—

Implicit fungal Sepsis

125

178

7.31

83.72

1.2

—

Maternal care for known or suspected fetal abnormality and damage

300

745

3.56

83.44

1.4

1.2

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

467

1050

2.84

83.37

1.2

1.3

—

Oral corticosteroids

1061

3213

1.97

83.19

1.2

—

Oxycodone

357

1048

3.12

82.81

1.3

1.2

—

Malignant neoplasm

793

2146

2.20

82.69

1.3

1.2

—

Insulin medication

618

2220

2.37

82.46

1.2

—

Chorioretinal inflammation

10.59

82.09

1.1

1.2

—

228

569

4.12

81.53

1.3

—

Other special examinations and investigations of persons without complaint or reported diagnosis

655

1380

2.42

80.70

1.2

—

All influenza

298

900

3.36

80.00

1.2

—

Cardiomyopathies, Primary/intrinsic

160

304

5.39

79.92

1.2

—

Hyperkalaemia

104

9.47

79.05

1.2

—

Cardiomyopathy (excluding other)

163

318

5.25

79.03

1.2

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

11.68

78.96

1.1

—

Intestinal infectious diseases

1122

3386

1.91

78.89

1.3

1.2

—

ILD, hospital admissions 3, with pneumonia sepsis

115

160

7.39

78.45

1.1

1.2

—

Any reimbursement code in KELA

711

1560

2.31

78.39

1.2

1.3

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

564

2139

2.38

77.53

1.2

—

Atrial fibrillation and flutter

273

472

3.79

77.10

1.2

1.3

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

582

2506

2.31

76.43

1.3

1.2

—

Disorders of other endocrine glands

510

2067

2.46

76.34

1.2

1.3

—

Diabetic maculopathy, excluding more controls

176

379

4.78

76.16

1.2

—

Idiopathic pulmonary fibrosis

108

146

7.63

75.63

1.1

1.2

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

543

1408

2.50

75.17

1.4

1.3

—

Drug-induced cataract

11.80

74.85

1.2

—

Other obstetric conditions, not elsewhere classified

546

1425

2.48

74.84

1.4

1.3

—

Neoplasms

915

2420

2.02

74.33

1.3

1.2

—

Gout, idiopatic and unspecified

234

635

3.74

74.05

1.2

1.1

—

Complications of medical and surgical care

697

3035

2.13

73.71

1.2

—

Nausea and vomiting

318

1033

3.06

72.72

1.2

1.3

—

Bronchitis

1051

3545

1.88

72.65

1.2

—

Abnormal findings on diagnostic imaging of lung

387

1366

2.74

72.45

1.2

—

Cardiomyopathy

196

478

4.18

72.11

1.2

—

Gout, unspecified

198

493

4.08

70.81

1.2

1.1

—

Acute upper respiratory infections of multiple and unspecified sites

814

3033

2.01

70.30

1.2

—

COPD/asthma related infections

976

2532

1.94

70.29

1.2

—

COPD/asthma/ILD related infections

976

2532

1.94

70.29

1.2

—

Cholangitis (primary sclerosing, PSC)

116

184

6.55

70.25

1.2

—

Hepatic failure, not elsewhere classified

105

8.97

70.21

1.2

1.3

—

Pregnancy examination and test

227

348

4.14

70.10

1.3

1.2

—

Maternal care for other known or suspected fetal problems

380

846

2.90

69.99

1.3

1.2

—

Non-ischemic cardiomyopathy

269

644

3.40

69.76

1.2

—

Other heart diseases, wide

943

3022

1.92

69.20

1.2

—

Senile cataract

489

1201

2.52

69.08

1.1

1.2

—

Type 1 diabetes

335

1187

2.86

68.25

1.2

1.3

—

Disorders of choroid and retina

676

2275

2.13

67.82

1.2

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

159

347

4.73

67.81

1.6

1.2

—

Protozoal diseases

9.30

67.60

1.2

—

Complications of surgical and medical care, not elsewhere classified

937

3422

1.89

66.93

1.2

—

Viral pneumonia

179

433

4.23

66.76

1.2

—

Other cataract

362

988

2.80

66.64

1.2

—

Vitreous haemorrhage

154

332

4.78

66.63

1.2

—

Care involving use of rehabilitation procedures

498

1970

2.34

66.61

1.2

—

Hepatocellular carcinoma

17.80

66.54

1.1

—

Other bacterial intestinal infections

206

554

3.78

66.19

1.3

1.2

—

Postpartum care and examination

206

314

4.24

66.16

1.4

1.1

—

Human immunodeficiency virus [HIV] disease

10.48

65.02

1.1

1.2

—

Need for immunization against other single viral diseases

11.00

64.73

1.2

—

Diabetic retinopathy, strict definition

233

598

3.53

64.69

1.2

—

Hypertensive heart and/or renal disease

210

407

3.90

64.69

1.1

1.2

—

Pneumocystosis

12.77

64.54

1.1

1.2

—

Other disorders of skin and subcutaneous tissue

601

2510

2.14

64.48

1.2

—

Presence of other functional implants

330

788

2.92

64.32

1.1

—

Bleeding

698

2435

2.05

63.92

1.2

—

Type 2 diabetes, wide definition

647

1958

2.13

63.61

1.2

—

Other diseases of pleura

355

1161

2.71

63.59

1.2

—

Congenital malformations, deformations and chromosomal abnormalities

692

3313

2.01

62.89

1.2

—

Gingival hyperplasia

132

7.49

62.87

1.2

1.3

—

Congenital malformations, deformations and chromosomal abnormalities

733

3460

1.97

62.72

1.2

—

Gout, strict definition

174

432

4.10

62.55

1.2

1.1

—

Other retinal disorders

512

1764

2.28

62.10

1.2

—

Viral infections characterized by skin and mucous membrane lesions

456

1963

2.35

62.08

1.2

—

Bacterial intestinal infections, IBD co-morbidities

204

570

3.64

61.99

1.3

1.2

—

Endocrine, nutritional and metabolic diseases

872

2303

1.93

61.96

1.2

1.3

—

Antihypertensive medication - note that there are other indications

783

2095

2.00

61.90

1.2

1.3

—

Insulin, intermediate and long-acting

494

2139

2.26

61.64

1.2

—

Cerebrovascular diseases (FINNGEN)

261

574

3.25

60.79

1.2

1.3

—

Oedema, not elsewhere classified

261

852

3.05

59.98

1.2

1.3

—

Autoimmune diseases

1081

3114

1.78

59.49

1.2

1.3

—

Diabetic retinopathy, excluding more controls

295

540

3.12

59.10

1.2

—

Supervision of high-risk pregnancy

250

449

3.41

58.94

1.4

1.2

—

Any death

475

1479

2.32

58.82

1.2

—

Used for control exclusion in common control thyroid runs

1040

2953

1.79

58.65

1.2

1.3

—

Persons encountering health services for examination and investigation

594

1380

2.17

57.53

1.2

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

142

6.82

57.45

1.2

—

Hypo-osmolality and hyponatraemia

158

387

4.12

57.31

1.1

1.2

—

Enterocolitis due to Clostridium difficile

133

288

4.72

57.16

1.4

1.2

—

Other pulmonary diagnosis

746

1903

1.98

56.58

1.2

1.3

—

Other diseases of biliary tract

115

224

5.27

56.03

1.2

—

Gout due to impairment of renal function

20.61

56.00

1.0

1.3

—

Drug-induced neutropenia

116

229

5.24

55.82

1.3

1.2

—

Excluding asthma or asthma-COPD overlap

743

1903

1.97

55.74

1.2

1.3

—

Other bacterial intestinal infections

238

783

3.08

55.61

1.3

1.2

—

Malaise and fatigue

409

1392

2.38

55.43

1.2

—

Outcome of delivery

211

364

3.65

55.41

1.5

1.2

—

Dilated cardiomyopathy

143

337

4.34

55.28

1.2

—

Mycoses

291

1076

2.74

54.93

1.3

1.2

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

10.39

54.69

1.2

1.3

—

Human immunodeficiency virus [HIV] disease resulting in other conditions

10.17

54.49

1.1

1.2

—

ILD differential diagnosis

738

1907

1.95

54.02

1.2

1.3

—

COPD differential diagnosis

738

1908

1.95

53.94

1.2

1.3

—

Disorders of lipoprotein metabolism and other lipidaemias

607

1847

2.05

53.65

1.1

1.2

—

Adjustment and management of implanted device

131

297

4.46

53.02

1.2

—

Streptococcal septicaemia

108

209

5.29

52.99

1.3

1.2

—

Sub-endpoint used in defining T1D endpoints

333

1317

2.52

52.81

1.2

—

Cardiomyopathy, other and unspecified

104

197

5.42

52.31

1.2

—

Erysipelas

372

1389

2.39

51.70

1.2

—

Type 1 diabetes, wide definition

280

1054

2.69

50.99

1.2

1.3

—

Tramadol

711

2311

1.90

50.98

1.2

—

Type 1 diabetes, wide definition, subgroup 1

269

996

2.74

50.63

1.2

1.3

—

Pneumonia due to other infectious organisms, not elsewhere classified

101

7.59

50.38

1.2

1.3

—

Acquired haemolytic anaemia

9.55

50.36

1.3

1.2

—

Paroxysmal tachycardia

215

576

3.16

50.31

1.2

1.3

—

Any event in cancer register

846

2795

1.79

49.95

1.3

1.2

—

Explicit bacterial Sepsis

127

298

4.35

49.37

1.2

—

Viral infections characterized by skin and mucous membrane lesions

813

3954

1.77

49.34

1.2

—

Personal history of other diseases and conditions

177

525

3.44

48.97

1.3

—

Procreative management

352

1235

2.40

48.86

1.3

1.2

—

Other and unspecified disorders of white blood cells

117

6.87

48.74

1.2

—

Other viral diseases, not elsewhere classified

242

869

2.83

48.20

1.2

1.3

—

Ulcer of lower limb, not elsewhere classified

139

355

3.98

48.18

1.1

1.2

—

Venous thromboembolism

404

1775

2.21

48.02

1.2

—

Chronic tubulo-interstitial nephritis

8.30

48.00

1.1

1.3

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

20.17

47.97

1.1

1.3

—

Haemolytic anaemias

117

6.82

47.59

1.2

—

Symptoms and signs involving the digestive system and abdomen

920

2659

1.74

47.57

1.2

—

Other and unspecified aplastic anaemias

17.56

47.52

1.3

1.4

—

Gastrointestinal diseases

612

1552

1.99

47.37

1.2

1.3

—

Atrial fibrillation and flutter with reimbursement

178

315

3.63

47.30

1.2

—

Heart failure and bmi 25plus

260

628

2.82

47.30

1.2

—

Other necrotizing vasculopathies

182

5.37

47.25

1.2

—

Bacterial pneumonia (organism specified)

374

1505

2.27

46.69

1.2

—

Unspecified nephritic syndrome

9.60

46.47

1.1

1.2

—

Disorders of calcium metabolism

174

5.44

46.44

1.2

—

L01XX Other antineoplastic agents

126

6.38

46.41

1.2

—

ILD-related respiratory insufficiency

8.81

46.26

1.1

1.2

—

Zoster [herpes zoster]

176

542

3.30

46.07

1.2

—

Disorders of mineral metabolism

112

252

4.56

46.05

1.3

1.2

—

Hypoplasia of dental enamel

12.62

45.89

1.5

1.4

—

Other disorders of white blood cells

170

5.48

45.58

1.2

—

Acute upper respiratory infections

909

3304

1.70

45.54

1.2

—

Headache

568

2363

1.93

45.20

1.2

1.3

—

Diabetic maculopathy

167

477

3.38

44.37

1.2

—

Erysipelas

471

1765

2.05

43.90

1.1

1.2

—

Coronary atherosclerosis

430

1270

2.16

43.76

1.1

1.2

—

Insulin, fast-acting (human)

201

693

2.96

43.51

1.2

—

Symptoms and signs involving the skin and subcutaneous tissue

620

3340

1.83

43.09

1.2

—

973

3035

1.66

43.04

1.2

—

Other viral diseases, not elsewhere classified

325

1413

2.32

43.04

1.2

1.3

—

Osteopathies and chondropathies

463

2156

2.02

42.76

1.2

—

Diabetic retinopathy

315

809

2.46

42.72

1.2

—

Zoster [herpes zoster]

380

1745

2.16

42.64

1.2

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

6.98

42.64

1.3

1.2

—

IBD (strict) with PSC

13.38

42.63

1.2

1.3

—

Other abnormal products of conception

433

1366

2.13

42.61

1.4

1.3

—

Other skin changes

176

569

3.14

42.54

1.2

—

Alcoholic liver disease

119

299

4.07

42.35

1.1

1.2

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

372

808

2.33

42.34

1.2

1.3

—

Periodontitis

791

3081

1.73

42.31

1.2

—

Pulmonary heart disease, diseases of pulmonary circulation

239

917

2.63

41.93

1.2

—

Chronic periodontitis, including avohilmo

788

3082

1.72

41.88

1.2

—

Bacterial pneumoniae

319

1221

2.32

41.74

1.2

—

Seborrhoeic keratosis

174

566

3.11

41.57

1.1

1.2

—

Hyperlipidaemia, other/unspecified

260

953

2.53

41.52

1.1

1.2

—

Hodgkin lymphoma, hilmo

115

6.43

41.26

1.2

—

Nonischemic cardiomyopathy

109

262

4.24

41.08

1.2

—

Colitis, primary sclerosing

10.05

40.66

1.2

1.3

—

Osteoporosis

184

580

2.99

40.59

1.2

—

Statin medication

620

1891

1.86

40.51

1.1

1.3

—

COPD-related respiratory insufficiency

107

260

4.18

39.78

1.1

1.2

—

Infections of the skin and subcutaneous tissue

565

3075

1.83

39.69

1.2

—

Spontaneous abortion

479

1653

1.97

38.97

1.3

1.2

—

Iridocyclitis

230

900

2.59

38.95

1.1

1.2

—

Bacterial pneumonia, not elsewhere classified

299

1146

2.32

38.94

1.2

—

Premature rupture of membranes

284

849

2.43

38.91

1.3

1.2

—

Diseases of arteries, arterioles and capillaries

467

1761

1.97

38.89

1.2

—

Congenital malformations of gallbladder, bile ducts and liver

12.42

38.68

1.2

—

Charcot foot

10.39

38.68

1.3

1.2

—

Other diseases of the respiratory system

161

527

3.09

38.10

1.2

—

Other respiratory disorders and diseases

161

527

3.09

38.10

1.2

—

Mature T/NK-cell lymphomas, hilmo

12.80

38.09

1.4

1.2

—

Other acute lower respiratory infections

469

2342

1.92

38.01

1.2

—

Diseases of the eye and adnexa

828

2479

1.68

37.90

1.2

1.3

—

Mantle cell lymphoma, including Hilmo

15.11

37.69

1.5

1.1

—

Respiratory insufficiency

114

5.95

37.58

1.2

—

Diseases of oesophagus, stomach and duodenum

905

3362

1.62

37.13

1.2

—

Nutritional anaemias

368

1726

2.07

36.92

1.2

—

Molar incisor enamel hypoplasia, with caries

14.46

36.91

1.5

1.4

—

Diseases of the skin and subcutaneous tissue

883

2722

1.63

36.35

1.2

—

Other and unspecified polyneuropathies, also in other diseases

164

559

2.97

36.22

1.2

—

Iron deficiency anaemia

329

1535

2.13

35.66

1.2

—

Missing teeth due to accident, extraction or parodontitis

421

2053

1.94

35.35

1.2

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

451

2394

1.89

35.33

1.1

1.2

—

Polyarthropathies

639

2410

1.74

35.28

1.2

—

Amputation

223

4.24

35.21

1.1

—

Chronic periodontitis, complicated

411

2101

1.95

35.20

1.2

—

Valvular heart disease excluding rheumatic fever

331

1114

2.16

35.07

1.2

—

Other infectious diseases

242

4.10

34.95

1.2

—

Other infectious diseases

110

303

3.71

34.45

1.3

1.2

—

Polyneuropathies and other disorders of the peripheral nervous system

179

658

2.75

34.37

1.1

1.2

—

Other pleural conditions

215

4.25

34.27

1.2

1.1

—

Pure hypercholesterolaemia

476

1653

1.89

34.23

1.1

1.2

—

Diabetes mellitus in pregnancy

417

1361

1.98

34.09

1.3

—

Gingivitis and periodontal diseases

817

2589

1.64

33.99

1.2

—

Other reaction to severe stress, and adjustment disorders

417

2193

1.92

33.91

1.3

—

Diabetes, varying definitions

875

3233

1.59

33.78

1.2

—

Diagnoses used for exclusion with ILD

202

797

2.56

33.64

1.2

—

Continuous positive airway pressure

155

440

3.00

33.48

1.2

—

Abdominal and pelvic pain

850

2659

1.61

33.28

1.2

—

Other diseases of liver

174

643

2.74

33.14

1.1

1.2

—

Dyspnoea

722

3258

1.65

33.14

1.2

—

Follicular lymphoma, hilmo

6.11

33.08

1.2

—

Ulcerative colitis (strict) with PSC

13.11

33.06

1.2

1.4

—

Caries of enamel

810

3675

1.60

32.90

1.3

1.2

—

Diabetes mellitus

878

3259

1.58

32.83

1.2

—

Systemic connective tissue disorders

278

1277

2.20

32.75

1.2

—

Colitis, primary sclerosing, strict definition

10.61

32.57

1.2

1.3

—

Acute bronchitis

339

1648

2.03

32.51

1.2

—

Other maternal disorders predominantly related to pregnancy

528

1851

1.80

32.34

1.3

—

Non-rheumatic valve diseases

320

1098

2.12

32.28

1.2

—

Isolated proteinuria

115

5.66

32.25

1.2

—

Peripheral artery operations in Hilmo

101

274

3.73

32.23

1.1

—

Diseases of the digestive system

349

1747

2.00

32.22

1.2

—

Sarcoidosis

138

457

3.07

32.19

1.2

—

Neurotic, stress-related and somatoform disorders

817

3617

1.59

32.16

1.3

1.2

—

Viral pneumonia (known virus, not influenza)

6.64

31.87

1.4

1.2

—

Habitual aborter

132

5.32

31.73

1.5

1.4

—

Anxiety disorders

820

3630

1.58

31.73

1.3

1.2

—

L01XE Protein kinase inhibitors

147

4.90

31.47

1.2

—

Other diseases of pericardium

103

5.78

31.40

1.1

1.2

—

Disorders of sclera, cornea, iris and ciliary body

471

2636

1.80

31.36

1.2

—

Amiodarone users

239

3.92

31.34

1.2

—

Gestational diabetes (for exclusion)

469

1799

1.83

30.90

1.3

—

Pacemaker

188

716

2.53

30.57

1.2

—

DVT of lower extremities and pulmonary embolism

283

1340

2.12

30.49

1.2

—

Other diseases of the digestive system

232

1023

2.29

30.22

1.2

—

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

7.01

30.18

1.2

1.1

—

Heart failure and hypertrophic cardiomyopathy

9.94

29.97

1.2

—

Abnormal findings on examination of urine, without diagnosis

162

4.59

29.84

1.3

1.2

—

Isolated proteinuria with specified morphological lesion

10.49

29.82

1.1

1.3

—

Opioids

882

2973

1.55

29.33

1.2

—

All influenza (not pneumonia)

152

560

2.75

29.18

1.3

1.2

—

GI-bleeding

228

1013

2.27

29.18

1.2

—

False labour

327

1008

2.04

29.00

1.3

1.2

—

Gastroduodenal ulcer

168

651

2.59

28.90

1.1

1.2

—

Melanocytic naevi

291

1430

2.06

28.88

1.3

1.2

—

Pulmonary embolism

200

844

2.39

28.85

1.2

—

ILD medications: pirfenidone

34.24

28.78

1.1

1.0

—

Antenatal screening

210

478

2.49

28.74

1.4

1.2

—

Special screening examination for infectious and parasitic diseases

288

1018

2.10

28.68

1.3

—

Secondary right heart disease

6.11

28.67

1.2

—

Phlebitis and thrombophlebitis (not including DVT)

187

771

2.45

28.48

1.2

—

Pulmonary heart disease

200

850

2.37

28.40

1.2

—

Other necrotizing vasculopathies (FG)

144

4.68

28.31

1.2

—

Anterior Iridocyclitis

193

812

2.41

28.15

1.1

1.2

—

Myelodysplastic syndrome

31.15

28.13

1.4

1.3

—

Dermatitis and eczema

928

3842

1.50

28.05

1.2

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

710

2688

1.60

28.02

1.2

—

Aspergillosis

12.21

27.97

1.4

1.3

—

Peripheral artery disease

251

923

2.18

27.92

1.1

—

Pleural effusion

108

337

3.24

27.84

1.1

1.2

—

Complications of procedures, not elsewhere classified

623

3192

1.62

27.73

1.2

—

Anxiety disorders, excluding more controls

739

3071

1.57

27.68

1.2

—

Ischaemic heart disease, wide definition

499

1781

1.74

27.55

1.1

1.2

—

Arthropathies in other diseases classified elsewhere

109

5.30

27.54

1.2

—

Other metabolic disorders

138

499

2.81

27.52

1.3

—

Early onset COPD, excluding more controls

138

498

2.79

27.48

1.1

1.2

—

Asthma, excluding more controls

576

1784

1.69

27.44

1.2

1.3

—

Single delivery by caesarean section

215

521

2.40

27.31

1.4

1.2

—

Autoimmune diseases related-to ILD

699

3827

1.57

27.20

1.2

—

Dermatitis

491

2889

1.70

27.09

1.2

—

Diseases of oral cavity, salivary glands and jaws

407

1124

1.87

27.04

1.2

—

Other CVD (FINNGEN)

169

3.90

26.53

1.1

1.2

—

Cardiac arrhythmias

517

1983

1.70

26.52

1.2

1.3

—

Supervision of normal pregnancy

197

463

2.45

26.33

1.3

1.2

—

Symptoms and signs involving the circulatory and respiratory systems

912

3057

1.50

26.22

1.2

—

Disorders of vitreous body and globe

326

1650

1.91

26.22

1.2

—

Localized swelling, mass and lump of skin and subcutaneous tissue

260

1272

2.06

26.14

1.2

—

Diseases of the respiratory system

537

1586

1.70

26.09

1.2

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

394

1260

1.85

25.96

1.4

1.2

—

Retinal detachments and breaks

224

1038

2.17

25.93

1.2

—

Acute and subacute iridocyclitis

182

775

2.38

25.89

1.1

1.2

—

Hypocalcemia

6.20

25.83

1.1

1.3

—

Type 2 diabetes

767

2921

1.54

25.73

1.2

—

Amputation of toe

177

4.09

25.69

1.2

—

Myeloproliferative diseases

209

3.80

25.51

1.2

—

Hypercalcemia

5.34

25.41

1.4

1.2

—

Viral warts

126

458

2.80

25.00

1.2

1.3

—

Hypertensive Heart Disease

132

373

2.79

24.89

1.1

1.2

—

Parasetamol

705

2287

1.57

24.86

1.2

1.3

—

Other diseases of urinary system

830

3122

1.50

24.47

1.3

1.2

—

Maternal care for known or suspected malpresentation of fetus

224

753

2.18

24.40

1.3

1.2

—

Unspecified human immunodeficiency virus [HIV] disease

9.06

24.36

1.1

1.3

—

Asthma (only as main-diagnosis), excluding more controls

519

1784

1.67

24.23

1.2

1.3

—

Diabetes, insulin treatment (Kela reimbursement)

737

2921

1.53

24.20

1.2

—

Maternal care for known or suspected abnormality of pelvic organs

266

896

2.04

24.15

1.4

1.2

—

Osteonecrosis

182

3.93

23.96

1.4

1.2

—

Cellulitis

202

929

2.20

23.96

1.2

—

Candidiasis

145

579

2.54

23.82

1.3

1.2

—

Other pulmonary heart/vessel disease

100

5.11

23.81

1.2

—

Other and unspecified iron deficiency

246

1223

2.02

23.65

1.2

—

Other complications of labour and delivery, not elsewhere classified

194

807

2.25

23.64

1.4

1.3

—

Other problems related to primary support group, including family circumstances

163

670

2.41

23.64

1.3

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

698

2921

1.54

23.63

1.2

—

Abnormalities of breathing

785

3045

1.50

23.60

1.2

1.3

—

Gastric ulcer

118

426

2.79

23.60

1.2

—

Chronic hepatitis, not elsewhere classified

113

4.84

23.51

1.2

1.3

—

Myocarditis

105

4.95

23.45

1.2

1.3

—

Reimbursement for rheumatic diseases

431

2547

1.69

23.44

1.2

—

STROKE

342

1265

1.85

23.40

1.2

—

Chronic apical periodontitis

922

3625

1.45

23.35

1.2

—

Asthma

579

1887

1.62

23.29

1.2

1.3

—

Disorders of vitreous body

309

1610

1.86

23.21

1.2

—

Viral pneumonia (unknown virus, not influenza)

289

3.22

23.01

1.1

1.2

—

Follow-up examination after treatment for conditions other than malignant neoplasms

332

1191

1.85

22.89

1.2

—

Other and unspecified dermatitis

409

2410

1.71

22.89

1.2

—

Persons encountering health services for specific procedures, not carried out

302

3.13

22.61

1.2

—

Secondary thrombocytopenia

9.51

22.29

1.2

1.3

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

333

1478

1.81

22.21

1.1

1.2

—

Disorders of tooth development and eruption

179

644

2.27

22.18

1.3

—

Dental operations

408

1200

1.75

22.17

1.2

—

Benign neoplasms

875

3327

1.46

22.16

1.2

—

Chronic myeloproliferative disease

8.95

22.10

1.4

1.2

—

Diseases of spleen

6.62

22.03

1.2

1.3

—

Asthma, unspecified (mode), excluding more controls

356

1505

1.78

22.00

1.2

—

Osteomyelitis

199

3.64

21.84

1.2

—

Pain, not elsewhere classified

214

1043

2.07

21.82

1.2

1.3

—

Other and unspecified coagulation defects

195

3.68

21.78

1.3

1.2

—

Symptoms and signs involving the urinary system

533

2564

1.59

21.72

1.2

—

Unspecified jaundice

113

4.60

21.53

1.2

—

Iron deficiency anaemia secondary to blood loss (chronic)

120

460

2.64

21.43

1.2

—

Other diseases of hard tissues of teeth

382

1123

1.77

21.36

1.2

—

Other gastritis (incl. Duodenitis)

157

683

2.32

21.32

1.2

—

Diabetes medication

823

3362

1.46

21.31

1.2

—

Viral and other specified intestinal infections

307

1642

1.82

21.25

1.3

—

Hydronephrosis

287

3.10

21.21

1.2

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

118

452

2.64

21.15

1.3

—

Other coagulation defects

279

3.14

21.00

1.3

1.2

—

Persons encountering health services in other circumstances

326

1839

1.77

20.98

1.2

—

Asthma (only as main-diagnosis)

521

1887

1.60

20.94

1.2

1.3

—

Postpartum haemorrhage

278

1265

1.87

20.47

1.3

—

Neovascular glaucoma

106

4.63

20.39

1.2

—

Hepatomegaly and splenomegaly, not elsewhere classified

8.94

20.38

1.2

1.1

—

Cystitis

675

2683

1.50

20.37

1.2

—

Cutaneous abscess, furuncle and carbuncle

242

1265

1.93

20.32

1.3

1.2

—

Haemorrhage, not elsewhere classified

5.62

20.13

1.2

—

Erectile dysfunction

210

3.44

20.13

1.2

1.1

—

Cardiac arrest

4.66

20.10

1.2

1.3

—

Abnormal findings on examination of blood, without diagnosis

322

1692

1.76

19.83

1.2

—

Chronic gastritis

157

707

2.23

19.65

1.2

—

Viral and other specified intestinal infections

245

1269

1.90

19.62

1.3

—

Other and unspecified diseases of blood and blood-forming organs

5.80

19.56

1.1

1.2

—

Background retinopathy and retinal vascular changes

6.33

19.51

1.1

—

Glaucoma secondary to other eye disorders

110

4.46

19.49

1.2

—

Single delivery by forceps and vacuum extractor

168

450

2.28

19.48

1.3

1.2

—

Solid cancers, helper endpoint

548

2088

1.56

19.44

1.2

—

ILD medications: nintedanib

38.81

19.41

1.2

1.0

—

Hypothyroidism (congenital or acquired)

271

812

1.90

19.39

1.3

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

135

4.02

19.37

1.1

—

Other congenital malformations of the digestive system

195

3.51

19.34

1.3

1.2

—

Poor fetal growth

189

925

2.08

19.33

1.3

—

Acute nephritic syndrome

5.57

19.17

1.1

1.2

—

Other inflammatory liver diseases

222

3.30

19.15

1.1

1.2

—

Diabetic neuropathy

111

433

2.59

19.04

1.2

—

Asthma (mode)

551

1907

1.55

19.04

1.2

1.3

—

Idiopathic gout

228

3.25

18.98

1.1

1.2

—

Candidiasis

255

1388

1.85

18.92

1.3

—

Asthma, unspecified (mode)

357

1591

1.70

18.86

1.2

—

Amputation of ankle bones

6.73

18.85

1.1

1.2

—

Other specified and unspecified retinal disorders

4.74

18.77

1.2

—

Haemorrhage in early pregnancy

256

1360

1.85

18.76

1.3

—

Any operation in hilmo

9.99

18.68

1.3

—

Perineal laceration during delivery

226

986

1.94

18.64

1.4

1.3

—

Mantle cell lymphoma

19.06

18.61

1.5

1.2

—

Atherosclerosis, excluding cerebral and coronary sclerosis

204

808

2.01

18.60

1.2

1.1

—

Other disorders of urethra and urinary system

515

2415

1.55

18.48

1.3

1.2

—

Arterial embolism and thrombosis

119

4.18

18.41

1.1

1.2

—

Presence of other devices

109

428

2.55

18.39

1.2

1.1

—

Disorders of gallbladder, biliary tract and pancreas

706

3078

1.45

18.24

1.2

—

Non-invasive ventilation

185

811

2.05

18.23

1.2

1.3

—

Benign neoplasm: Colon

300

1650

1.74

18.20

1.2

—

Chronic iridocyclitis

180

3.52

18.18

1.1

1.3

—

Other or ill-defined heart diseases

162

3.64

17.97

1.1

1.2

—

Disorders of oesophagus in diseases classified elsewhere

6.88

17.95

1.2

—

Haemorrhage from respiratory passages

216

1019

1.92

17.78

1.2

—

Acute lymphocytic leukaemia, helper endpoint

8.06

17.69

1.3

—

Acute lymphocytic leukaemia

8.06

17.69

1.3

—

Acute lymphocytic leukaemia, including Hilmo

8.06

17.69

1.3

—

Unspecified acute lower respiratory infection

137

611

2.27

17.69

1.4

1.2

—

Unspecified haematuria

262

1205

1.81

17.69

1.1

1.2

—

Pericarditis

4.66

17.57

1.2

1.1

—

Osteonecrosis due to drugs

7.36

17.54

1.4

1.2

—

Benign neoplasm of colon, rectum, anus and anal canal

355

1873

1.65

17.42

1.2

—

Gastro-oesophageal reflux disease

460

2566

1.55

17.40

1.2

—

Maternal care for other conditions predominantly related to pregnancy

233

1243

1.86

17.36

1.3

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

110

450

2.47

17.27

1.2

—

Viral warts

207

1087

1.92

17.26

1.2

1.3

—

Noninfective enteritis and colitis

373

2313

1.62

17.20

1.2

—

Pre-eclampsia or poor fetal growth

315

1870

1.69

17.16

1.3

—

Volume depletion

227

3.12

17.12

1.2

—

Symptoms and signs concerning food and fluid intake

275

2.90

17.01

1.1

1.2

—

Cystic disease of liver

18.07

16.99

1.1

1.2

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

6.24

16.95

1.1

1.2

—

Retinal vascular occlusion

239

3.04

16.91

1.2

—

Other congenital malformations of the digestive system

233

3.09

16.88

1.3

—

Primary biliary cholangitis (PBC)

6.40

16.83

1.3

1.4

—

Hypertrophic cardiomyopathy

124

3.96

16.70

1.2

—

Other embolism and thrombosis

386

2.57

16.69

1.1

1.2

—

Actinic keratosis

160

714

2.08

16.69

1.1

—

Other CVD

111

463

2.41

16.68

1.1

1.2

—

Retinal vascular disorders

241

3.02

16.67

1.2

—

Hypothyroidism and >3 levothyroxin purchases

260

810

1.83

16.64

1.3

—

Hypothyroidism, levothyroxine purchases

260

810

1.83

16.64

1.3

—

Idiopathic thrombocytopenic purpura

107

4.23

16.64

1.2

—

Retinal haemorrhage

6.07

16.59

1.3

1.2

—

COPD (mode)

144

518

2.19

16.57

1.1

1.2

—

Immunodeficiency with predominantly antibody defects

4.46

16.52

1.3

—

Other diseases of intestines

878

3644

1.37

16.45

1.2

—

Syncope and collapse

263

1282

1.76

16.39

1.2

—

Molar incisor enamel hypoplasia

185

3.33

16.38

1.5

1.3

—

Disorders of skin appendages

418

2697

1.56

16.32

1.2

—

Asthma-related pneumonia or sepsis

240

1340

1.80

16.31

1.2

—

Asthma, hospital admissions 3, pneumonia

240

1340

1.80

16.31

1.2

—

Other diseases of blood and blood-forming organs

203

3.20

16.30

1.1

1.2

—

Visual disturbances and blindness

366

2293

1.60

16.27

1.2

—

Asthma-related pneumonia

239

1335

1.80

16.22

1.2

—

Carcinoma in situ of skin

159

3.50

16.19

1.2

—

Other disorders of lacrimal gland

243

1369

1.79

16.16

1.2

—

Skin changes due to chronic exposure to nonionizing radiation

164

745

2.04

16.14

1.1

—

Other diseases of arteries and capillaries

273

2.86

16.14

1.2

—

Hypoplasia of dental enamel , including avohilmo

174

3.40

16.12

1.4

1.3

—

Covid-19 suspected case

214

1162

1.86

16.12

1.3

—

Complications of labour and delivery

473

1712

1.54

16.12

1.3

1.2

—

SLE (Finngen)

101

4.26

16.09

1.0

1.3

—

Rare circulating lymphoid malignancy

36.72

16.06

1.3

1.5

—

Delivery, wide proxy

211

580

1.94

16.05

1.4

1.2

—

Pregnancy with abortive outcome

517

1787

1.52

16.03

1.3

1.2

—

Disorders of lacrimal system

283

1665

1.70

15.98

1.2

—

Herpesviral [herpes simplex] infections

111

474

2.37

15.93

1.2

—

Other autoimmune haemolytic anaemias

12.37

15.77

1.3

—

All anxiety disorders

563

3057

1.46

15.77

1.3

1.2

—

Budesonide

126

571

2.23

15.71

1.3

—

Immunodeficiencies

173

3.37

15.65

1.2

—

Acute lymphadenitis

273

2.84

15.63

1.2

—

Female infertility

327

1198

1.67

15.60

1.3

—

Melanocytic naevi, other sites/unspecified

347

2.61

15.58

1.2

—

Other specified disorders of kidney and ureter

4.34

15.33

1.1

1.2

—

Other noninfective gastroenteritis and colitis

192

1023

1.89

15.31

1.2

1.3

—

Acute sinusitis

441

2701

1.52

15.28

1.2

—

Other arterial embolism and thrombosis

5.04

15.06

1.2

—

Diseases of pulp and periapical tissues and dental caries

453

1515

1.54

14.97

1.2

—

Visual impairment including blindness (binocular or monocular)

188

3.18

14.94

1.1

1.2

—

Other and unspecified iridocyclitis

174

3.29

14.83

1.1

1.2

—

Melanocytic naevi of trunk

121

556

2.20

14.65

1.2

—

Other disorders of conjunctiva

100

425

2.38

14.52

1.2

—

Anxiety (asthma-related co-morbidities)

552

2970

1.44

14.50

1.2

—

Hernia of abdominal wall

306

1898

1.62

14.29

1.2

—

Medical treatment for female infertility

244

1421

1.72

14.28

1.3

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

302

1847

1.63

14.27

1.3

—

Peripheral arterial reconstruction

345

2.51

14.14

1.1

—

Pregnancy, childbirth and the puerperium

174

461

1.98

14.02

1.3

1.2

—

Systemic lupus erythematosus

113

3.80

13.86

1.0

1.3

—

Diverticular disease of intestine

399

1665

1.53

13.78

1.1

1.2

—

Cardiodefibrillation

185

1008

1.84

13.70

1.2

1.1

—

AV-block

335

2.42

13.66

1.2

—

Hypotension

369

2.43

13.65

1.1

1.2

—

Pain (limb, back, neck, head abdominally)

575

2012

1.44

13.64

1.2

—

172

842

1.88

13.48

1.1

—

Labour and delivery complicated by fetal stress [distress]

270

1061

1.68

13.47

1.3

—

Papilloedema, unspecified

4.11

13.46

1.1

1.3

—

Cardiomyopathy, Hypertrophic obstructive

5.72

13.44

1.1

1.2

—

Cough

277

1612

1.63

13.30

1.2

—

Chronic ulcer of skin, not elsewhere classified

160

3.23

13.28

1.2

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

437

2.30

13.26

1.3

1.2

—

Dysphagia

144

733

1.98

13.24

1.2

—

Disease of hard tissues of teeth, NOS

338

1113

1.59

13.22

1.2

—

Persons encountering health services in circumstances related to reproduction

421

1898

1.50

13.20

1.3

1.2

—

Chronic myeloid leukaemia, including Hilmo

13.75

13.11

1.1

—

Myocardial infarction

237

975

1.72

13.09

1.1

1.2

—

Squamous cell neoplasms and carcinomas of the skin

4.41

13.06

1.1

—

Inflammatory diseases of the central nervous system

330

2.49

13.00

1.2

—

Hypokalaemia

318

2.51

12.96

1.3

1.2

—

Conjunctivitis (acute, non atopic)

240

1432

1.68

12.96

1.3

1.2

—

Tuberculosis of other organs, strict

5.70

12.94

1.1

1.2

—

Female infertility, cervical, vaginal, other or unspecified origin

290

1165

1.63

12.92

1.3

—

Other congenital malformations of urinary system

11.68

12.64

1.5

1.2

—

Sequelae of external causes of morbidity and mortality

171

937

1.84

12.61

1.2

—

Marginal zone B-cell lymphoma, including Hilmo

9.63

12.59

1.1

—

Wegener granulomatosis

5.40

12.59

1.1

1.3

—

Myeloproliferative diseases (CML excluded)

192

2.95

12.56

1.3

1.2

—

Umbilical hernia

206

1195

1.74

12.53

1.2

—

Encephalitis

112

3.66

12.51

1.2

1.3

—

SLE, ICD10

112

3.65

12.49

1.1

1.3

—

SLE, strict definition

112

3.65

12.49

1.1

1.3

—

Other mycoses, not elsewhere classified/unspecified

20.65

12.46

1.4

1.6

—

Fluid overload

30.66

12.43

1.1

1.3

—

Endocarditis

4.07

12.41

1.1

1.2

—

Diseases of middle ear and mastoid

519

3013

1.41

12.40

1.2

—

Cerebral cysts

251

2.67

12.25

1.2

1.3

—

Disorder of lipoprotein metabolism, unspecified

285

2.55

12.25

1.2

—

DVT of lower extremities

113

543

2.10

12.23

1.2

—

conjunctival haemorrhage

206

2.85

12.22

1.2

—

Abnormal findings on diagnostic imaging of other body structures

427

2.24

12.19

1.2

—

Aortic valve malfunction, age under 60 years

390

2.31

12.17

1.2

—

Osteoporosis with pathological fracture (FG)

114

3.54

12.11

1.2

—

Other diseases of stomach and duodenum

154

3.16

12.08

1.2

—

Other soft tissue disorders, not elsewhere classified

753

3312

1.34

12.03

1.2

—

Other encephalitis

106

3.68

11.96

1.2

1.3

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

192

2.90

11.96

1.4

1.2

—

Family history of certain disabilities and chronic diseases leading to disablement

209

2.82

11.95

1.5

1.3

—

Dental caries, including avohilmo

492

1757

1.44

11.83

1.2

—

Syphilis

3.92

11.72

1.1

1.2

—

Syphilis

3.92

11.72

1.1

1.2

—

Tuberculosis of other organs

5.63

11.69

1.0

1.2

—

Encephalopathy

9.73

11.67

1.2

—

Abnormal results of function studies

335

2.39

11.66

1.2

—

Thrombotic microangiopathy

12.79

11.58

1.2

1.3

—

Acute posthaemorrhagic anaemia

4.33

11.51

1.1

1.2

—

Hypertension, portal

22.89

11.50

1.0

1.3

—

Amputation of foot

4.60

11.48

1.1

1.2

—

Single spontaneous delivery

241

767

1.67

11.45

1.3

1.2

—

Vocal cord dysfunction

391

2.19

11.38

1.2

1.3

—

Other and unspecified vascular occlusions

176

2.92

11.32

1.1

—

Osteopathy in diseases classified elsewhere

11.93

11.25

1.4

1.2

—

Mycoses

639

4152

1.34

11.24

1.3

1.2

—

Hypersensitivity angiitis

15.21

11.24

1.2

1.1

—

Diseases of pulp and periapical tissues, including avohilmo

795

3137

1.32

11.21

1.2

—

Other leukaemias of specified cell type

25.25

11.10

1.4

1.1

—

Malignant neoplasm of digestive organs

159

693

1.82

11.02

1.2

1.1

—

Convulsions, not elsewhere classified

165

921

1.78

11.01

1.2

1.3

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

201

800

1.71

10.99

1.1

—

Tubulo-interstitial nephritis, not specified as acute or chronic

185

2.84

10.96

1.1

1.2

—

Chronic myeloid leukaemia [CML], BCR/ABL-positive

9.33

10.94

1.1

1.2

—

Other and unspecified local infections of skin and subcutaneous tissue

370

2.27

10.94

1.3

1.2

—

Carcinoma in situ of skin of other and unspecified parts of face

122

3.31

10.94

1.2

1.1

—

Injury, poisoning and certain other consequences of external causes

465

1635

1.43

10.92

1.2

1.3

—

Hypersplenism

23.46

10.91

1.2

1.4

—

Unspecified contracted kidney

13.94

10.87

1.1

1.3

—

Diaphragmatic hernia

188

1110

1.70

10.78

1.2

—

Other disorders of glucose regulation and pancreatic internal secretion

341

2.31

10.77

1.2

—

Polyhydramnios

227

2.65

10.77

1.2

1.3

—

Hernia

633

3171

1.34

10.70

1.2

—

Other local infections of skin and subcutaneous tissue

393

2.21

10.68

1.3

1.2

—

Renal agenesis and other reduction defects of kidney

13.04

10.58

1.0

1.7

—

Asthma, hospital admission 2, infections

416

2879

1.42

10.52

1.2

—

Asthma-related infections

416

2879

1.42

10.52

1.2

—

Retinal detachment with retinal break

338

2.30

10.51

1.2

—

Delivery

238

770

1.64

10.51

1.3

1.2

—

Other disorders of optic [2nd] nerve and visual pathways

242

2.56

10.45

1.1

1.2

—

Sequelae with surgical and medical care as external cause

128

682

1.89

10.42

1.3

1.2

—

Other and unspecified acquired haemolytic anaemias

11.10

10.41

1.1

1.3

—

Neurological diseases, wide definition

316

1041

1.53

10.40

1.2

1.3

—

Visual disturbances

321

2168

1.49

10.38

1.2

—

Elevated blood glucose level

297

2.38

10.37

1.2

—

Malignant immunoproliferative diseases

7.86

10.36

1.2

—

Depression

743

3871

1.30

10.34

1.2

—

Other general symptoms and signs

157

2.94

10.28

1.2

1.3

—

Polycythaemia vera

4.59

10.26

1.2

1.1

—

Glaucoma

271

1517

1.54

10.23

1.1

1.2

—

Late syphilis

5.45

10.19

1.3

1.2

—

Acute pancreatitis

121

638

1.91

10.17

1.2

—

Preterm labour and delivery

184

1099

1.68

10.16

1.2

—

Failed induction of labour

403

2.17

10.13

1.4

1.3

—

Urolithiasis

196

1191

1.65

10.12

1.2

—

Conduction disorders

152

691

1.79

10.12

1.2

—

Renal agenesis and other reduction defects of kidney

13.28

10.09

1.0

1.8

—

Postpartum hemorraghe, all women as controls

278

1808

1.52

10.06

1.3

—

Dermatophytosis

436

2.11

10.04

1.2

—

Corns and callosities

206

2.65

10.01

1.2

—

Persons with potential health hazards related to communicable diseases

376

2618

1.43

9.94

1.2

1.3

—

Hypoplasia of dental enamel, prenatal

21.55

9.89

1.6

1.3

—

Infections with a predominantly sexual mode of transmission

299

2013

1.49

9.83

1.2

1.3

—

Other diseases of intestine

420

2.11

9.81

1.2

—

Cerebrovascular diseases

390

1924

1.43

9.77

1.2

—

Toxoplasmosis

12.24

9.76

1.5

—

Major coronary heart disease event excluding revascularizations

276

1203

1.53

9.76

1.1

1.2

—

Other renal tubulo-interstitial diseases

4.15

9.74

1.2

1.3

—

Use of antiglaucoma preparations and miotics

153

2.90

9.69

1.2

—

Fibrosis of liver

10.67

9.69

1.2

—

Dermatitis due to substances taken internally

204

2.64

9.68

1.2

—

Fitting and adjustment of other devices

130

640

1.84

9.67

1.2

—

Myocardial infarction, strict

209

918

1.63

9.62

1.1

1.2

—

External causes of morbidity and mortality

548

2027

1.36

9.60

1.2

1.3

—

6-mercaptopurine

149

2.94

9.59

1.2

—

Haemolytic-uraemic syndrome

16.12

9.59

1.3

1.4

—

Benign neoplasm: Transverse colon

283

2.35

9.56

1.1

1.2

—

Malignant melanoma, including Hilmo

365

2.18

9.56

1.2

—

Other noninfective disorders of lymphatic vessels and lymph nodes

3.42

9.48

1.2

1.3

—

Functional dyspepsia

173

1037

1.68

9.46

1.2

—

Prolonged pregnancy

152

767

1.75

9.40

1.3

1.2

—

Acute pancreatitis (for exclusion)

121

656

1.86

9.38

1.2

—

Systemic lupus erythematosus, unspecified

104

3.34

9.36

1.1

1.3

—

Diseases of tongue

151

2.88

9.33

1.3

1.2

—

Complications predominantly related to the puerperium

243

1588

1.54

9.31

1.3

—

Other diseases of pancreas

220

2.53

9.28

1.2

—

Early onset COPD

138

782

1.78

9.26

1.1

1.2

—

Depression medications

261

848

1.55

9.25

1.2

1.3

—

Other disorders of amniotic fluid and membranes

132

721

1.80

9.24

1.3

1.2

—

Congenital malformation of biliary tract

14.52

9.23

1.4

1.2

—

Other symptoms and signs involving the digestive system and abdomen

105

547

1.93

9.20

1.2

—

Degenerative macular diseases

227

2.48

9.17

1.1

—

Acquired absence of organs, not elsewhere classified

8.57

9.15

1.1

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

20.50

9.15

1.7

1.3

—

Diseases of the ear and mastoid process

901

3604

1.26

9.02

1.2

—

Inflammatory diseases of female pelvic organs

459

2476

1.37

9.01

1.3

—

Antepartum haemorrhage, not elsewhere classified

443

2.03

8.95

1.4

1.2

—

Other and unspecified immunodeficiencies with predominantly antibody defects

4.64

8.92

1.4

1.3

—

Congenital malformations of the circulatory system

125

675

1.81

8.90

1.3

—

Mood disorders, excluding more controls

681

3147

1.29

8.90

1.2

—

Viral hepatitis, IBD co-morbidity

237

2.43

8.89

1.2

1.3

—

Portal vein thrombosis

5.00

8.89

1.2

—

Noninfectious colitis NAS

110

591

1.88

8.82

1.2

—

Codeine

695

2929

1.29

8.80

1.2

—

Degeneration of macula and posterior pole

181

883

1.64

8.76

1.1

—

Pain in throat and chest

608

2791

1.31

8.75

1.2

—

Malignant neoplasm of skin

204

878

1.60

8.72

1.1

—

Toxic liver disease

4.88

8.64

1.2

1.3

—

Other obstructive and reflux uropathy

158

2.76

8.63

1.2

—

Type 2 diabetes, definitions combined

596

2671

1.31

8.63

1.2

—

Emphysema

175

2.65

8.61

1.2

—

Misadventures to patients during surgical and medical care

484

1.96

8.57

1.2

—

Other endophthalmitis

13.60

8.51

1.2

1.5

—

Other functional intestinal disorders

272

1716

1.48

8.51

1.2

—

Disorders of conjunctiva

617

3832

1.30

8.51

1.2

—

Moderate visual impairment, binocular

4.21

8.48

1.1

1.3

—

Intestinal stricture

159

962

1.66

8.43

1.2

—

Other abnormalities of plasma proteins

4.76

8.40

1.2

—

Non-allergic asthma (mode), excluding more controls

103

545

1.88

8.38

1.2

1.3

—

Mood disorders

762

3909

1.26

8.37

1.2

—

Other disorders of eye and adnexa

116

645

1.81

8.37

1.2

1.3

—

Mood [affective] disorders

761

3910

1.26

8.36

1.2

—

5-aminosalicylic acid

161

981

1.65

8.34

1.3

—

Benign neoplasm of other and ill-defined parts of digestive system

524

1.90

8.32

1.1

1.2

—

Hypoglycaemia, other or unspecified

276

2.27

8.31

1.2

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

341

2.13

8.28

1.1

1.2

—

Pruritus

442

1.99

8.28

1.2

1.3

—

Oxicams

858

0.50

8.27

1.2

—

Excessive attrition of teeth

433

3217

1.35

8.25

1.2

—

Subjective visual disturbances

170

1053

1.62

8.25

1.2

—

Drug-induced osteoporosis with pathological fracture

6.64

8.25

1.4

1.2

—

Other mycoses, not elsewhere classified/unspecified

4.01

8.21

1.3

—

Calculus of kidney and ureter

179

1124

1.60

8.20

1.2

—

Artrosis, including avohilmo

345

2628

0.72

8.19

1.2

—

Hydrocele

356

2.09

8.16

1.2

—

Other and unspecified drugs and medicaments

317

2.17

8.15

1.1

1.2

—

Abnormal findings on antenatal screening of mother

112

623

1.82

8.13

1.4

1.3

—

Other arthritis (FG)

204

1324

1.55

8.11

1.2

—

Pulmonary oedema

6.94

8.10

1.1

1.4

—

Exposure to unspecified factor

723

4124

1.26

8.10

1.2

—

Need for other prophylactic measures

217

2.43

8.09

1.1

1.3

—

Keratitis

244

1646

1.49

8.08

1.2

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

104

3.17

8.06

1.4

1.2

—

Membranous nephropathy

14.11

8.05

1.2

1.3

—

Type 2 diabetes, strict (exclude DM1)

599

2715

1.30

8.03

1.2

—

Use of pramipexole

118

668

1.78

8.01

1.2

—

Lichen simplex chronicus and prurigo

188

2.53

7.99

1.1

1.2

—

Cholecystitis

359

2.07

7.98

1.3

1.2

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

115

548

1.80

7.98

1.1

1.2

—

Infections with a predominantly sexual mode of transmission

378

2574

1.37

7.95

1.2

1.3

—

Long labour

212

1188

1.54

7.95

1.3

—

Chronic pancreatitis

387

2.03

7.94

1.1

1.2

—

Tuberculosis, IBD comorbidity

137

2.80

7.90

1.1

—

Other diseases of anus and rectum

165

1025

1.61

7.85

1.2

—

Valvular operations

342

2.09

7.81

1.3

1.2

—

Late syphilis

4.28

7.79

1.3

1.2

—

Other and unspecified follicular disorders

179

2.56

7.78

1.0

1.2

—

Traction detachment of retina

7.75

7.78

1.2

—

Constipation

543

2887

1.30

7.78

1.2

—

Restrictive cardiomyopathy

19.88

7.75

1.8

1.0

—

Polyarteritis nodosa and related conditions

4.44

7.74

1.3

—

Complications following infusion, transfusion and therapeutic injection

4.43

7.73

1.4

1.3

—

Stomatitis and related lesions

146

886

1.66

7.73

1.2

1.3

—

Disorders of globe

3.92

7.73

1.2

—

Other disorders starting during childhood or adolecense, excluding more controls

285

2.18

7.71

1.5

1.4

—

COPD, hospital admission 2, with asthma infections

141

722

1.68

7.71

1.1

1.2

—

Calcific aortic valvular stenosis, operated

109

590

1.80

7.71

1.1

—

Calcific aortic valvular stenosis

109

590

1.80

7.71

1.1

—

Operations 2 for CAVS

108

583

1.80

7.70

1.1

—

Calcific aortic valvular stenosis, diagnosis (helper)

108

583

1.80

7.70

1.1

—

Decubitus ulcer and pressure area

128

2.84

7.69

1.2

—

Erosion of teeth , including avohilmo

215

1430

1.51

7.68

1.3

—

Invasive ventilation

241

2.31

7.68

1.2

—

Other anxiety disorders

400

2570

1.35

7.63

1.3

—

Acquired absence of limb

9.15

7.61

1.1

1.0

—

Calcific aortic valvular stenosis, including rheumatic fever

108

585

1.79

7.60

1.1

—

Shock, not elsewhere classified

10.34

7.59

1.1

1.2

—

Caries of dentine, including avohilmo

521

2026

1.32

7.58

1.2

—

Pneumothorax

199

2.44

7.58

1.3

1.2

—

Disseminated intravascular coagulation [defibrination syndrome]

14.68

7.57

1.2

—

Disorders of plasma-protein metabolism, not elsewhere classified

6.82

7.56

1.2

1.4

—

In situ neoplasms

214

1426

1.51

7.56

1.2

—

Pain in limb

611

3200

1.28

7.55

1.2

—

Other Crohn's disease

341

2.08

7.54

1.2

—

Malignant melanoma of skin, including Hilmo

307

2.13

7.54

1.2

—

Non-allergic asthma (mode)

103

565

1.81

7.53

1.2

1.3

—

Dermatopolymyositis

4.50

7.48

1.2

1.3

—

Disorders of optic nerve and visual pathways

431

1.94

7.47

1.1

1.2

—

Amyloidosis, other/unspecified

4.48

7.47

1.5

1.1

—

Other specified/unspecified arthritis

185

1199

1.55

7.45

1.2

—

Other specified/unspecified bacterial intestinal infections

201

2.41

7.43

1.3

1.2

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

17.30

7.40

1.1

—

Carcinoma in situ of skin of trunk

3.78

7.37

1.2

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

358

2282

1.37

7.37

1.2

1.3

—

Special screening examination for neoplasms

115

2.89

7.32

1.1

1.3

—

Acute generalized exanthematous pustulosis

155

2.62

7.30

1.3

—

Sickle-cell disorders

22.01

7.30

1.0

1.6

—

Inflammatory bowel disease

239

1643

1.46

7.26

1.2

—

Other diseases of lip and oral mucosa

250

1733

1.45

7.25

1.2

—

Disorders of eyelid, lacrimal system and orbit

538

3173

1.29

7.24

1.2

—

Hyphaema and other vascular disorders of iris and ciliary body

3.75

7.23

1.3

1.2

—

Coxibs

125

1091

0.60

7.18

1.2

—

Other arrhythmias

392

2202

1.35

7.14

1.2

—

Explicit fungal Sepsis

10.48

7.12

1.3

1.4

—

Epilepsy

206

1376

1.50

7.12

1.2

1.3

—

Pregnancy hypertension

332

2171

1.38

7.07

1.3

—

Obstructed labour due to malposition and malpresentation of fetus

191

1176

1.52

7.04

1.3

—

Intracerebral haemorrhage

276

2.15

7.04

1.2

1.1

—

Carcinoma in situ of skin of scalp and neck

4.25

7.03

1.1

1.2

—

Other disorders of iris and ciliary body

3.27

7.00

1.3

1.2

—

Congenital malformations of heart and great arteries

108

602

1.75

7.00

1.3

—

IBD patients in KELA-register

188

1242

1.52

6.98

1.3

1.2

—

Marginal zone B-cell lymphoma

7.81

6.98

1.1

—

Type 2 diabetes, definitions combined, including avohilmo

598

2740

1.27

6.97

1.2

—

Microscopic polyangiitis

8.74

6.94

1.2

—

Benign neoplasm: Colon, unspecified

117

690

1.70

6.93

1.2

—

Sequelae of cerebrovascular disease

152

823

1.60

6.89

1.1

1.2

—

Generalized skin eruption due to drugs and medicaments

148

2.61

6.89

1.3

1.2

—

Herpesviral [herpes simplex] infections

192

1278

1.51

6.89

1.2

1.3

—

Hypoparathyroidism

3.21

6.86

1.2

1.3

—

Nonhereditary hypogammaglobulinemia

5.84

6.84

1.1

1.3

—

Chronic myeloid leukaemia

17.63

6.83

1.0

1.2

—

Other epidermal thickening

137

2.66

6.82

1.1

1.2

—

Benign neoplasm: Skin of other and unspecified parts of face

320

2.05

6.82

1.2

—

Tuberculosis, wide

155

2.53

6.76

1.1

1.2

—

Inflammatory bowel disease, strict (require KELA)

188

1253

1.51

6.72

1.3

—

Nonspecific lymphadenitis

250

2.18

6.67

1.3

1.2

—

Malignant melanoma

296

2.07

6.65

1.2

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

164

719

1.57

6.63

1.1

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

9.03

6.63

1.2

1.1

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

181

2.39

6.60

1.1

—

Paralytic ileus and intestinal obstruction

125

761

1.65

6.57

1.1

1.2

—

COPD related to multimorbidity

165

902

1.55

6.56

1.1

—

Neurological diseases

696

2816

1.24

6.52

1.2

1.3

—

Ulcerative colitis

184

1229

1.50

6.52

1.2

—

Undetermined asthma, excluding more controls

360

1.95

6.50

1.2

1.3

—

Allergic bronchopulmonary aspergillosis (ABPA)

15.18

6.49

1.2

1.3

—

Hypoplasia of dental enamel, prenatal , including avohilmo

6.43

6.49

1.5

1.2

—

Suppurative and unspecified otitis media

334

2196

1.35

6.46

1.3

—

Scleritis and episcleritis

234

2.20

6.45

1.1

1.2

—

Other benign neoplasms of skin

196

1329

1.48

6.43

1.2

—

Diseases of the musculoskeletal system and connective tissue

497

1931

1.29

6.43

1.2

1.3

—

Adrenocortical insufficiency

113

2.78

6.40

1.1

1.3

—

Acquired pure red cell aplasia [erythroblastopenia]

11.71

6.40

1.1

1.3

—

Other specified/unspecified systemic involvement of connective tissue

184

2.36

6.40

1.2

—

Dermatopolymyositis (FG)

4.15

6.40

1.2

1.3

—

Ocular pain

363

1.95

6.39

1.2

—

Vascular disorders of the intestines

130

2.63

6.38

1.1

1.2

—

Convalescence

136

2.60

6.38

1.4

1.3

—

Status epilepticus

119

2.73

6.36

1.2

—

Noninflammatory disorders of female genital tract

354

1314

1.36

6.36

1.3

—

Other and unspecified disorders of skin and subcutaneous tissue

191

2.33

6.34

1.2

—

Abnormalities of heart beat

216

1467

1.45

6.33

1.2

—

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

5.58

6.33

1.1

1.2

—

Acute bronchiolitis

283

2.03

6.32

1.3

—

Angina pectoris

238

1107

1.44

6.31

1.1

1.2

—

Other neurological diseases

388

2315

1.32

6.29

1.2

—

Malignant neoplasm, without specification of site, including Hilmo

3.47

6.28

1.3

1.1

—

Any mental disorder

775

3175

1.22

6.27

1.2

—

Recurrent and persistent haematuria

5.55

6.24

1.1

1.3

—

Scleritis

5.15

6.24

1.0

1.3

—

Drug-induced adrenocortical insufficiency

3.73

6.23

1.1

1.2

—

316

2325

1.35

6.22

1.2

—

Other systemic involvement of connective tissue (FG)

142

895

1.57

6.17

1.2

—

Ventral hernia

125

775

1.62

6.17

1.2

—

Other aneurysm

127

2.62

6.14

1.2

—

Benign neoplasm: Stomach

252

2.12

6.13

1.1

1.2

—

Postpartum hemorraghe, parous women as controls

278

1721

1.38

6.13

1.3

—

Benign neoplasm: Sigmoid colon

534

1.75

6.13

1.1

1.2

—

Other proliferative retinopathy

10.58

6.12

1.1

1.4

—

Diseases of male genital organs

340

1269

1.36

6.11

1.2

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

6.91

6.10

1.4

1.3

—

Finngen Rheumatological endpoints

722

3355

1.23

6.09

1.2

—

Type 1 diabetes, definitions combined

557

1.73

6.07

1.2

1.3

—

Other disorders starting during childhood or adolescence

325

1.98

6.07

1.5

1.3

—

Undetermined asthma

369

1.91

6.07

1.2

1.3

—

Malignant cancer of tonsil and base of tongue, including Hilmo

3.64

6.06

1.1

—

Acute suppurative otitis media

266

1799

1.39

6.05

1.3

—

Other specified/unspecified necrotizing vasculopathies

5.66

6.04

1.1

1.2

—

Other condition

108

650

1.67

6.02

1.3

1.2

—

Biliary cirrhosis, NAS

16.21

6.02

1.2

—

Other complications of surgical and medical care, not elsewhere classified

357

1.92

6.00

1.2

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

351

1.93

6.00

1.5

1.3

—

Fentanyl

234

2.14

6.00

1.2

—

Glaucoma suspect

161

1066

1.52

5.97

1.1

1.2

—

Kela reimbursement Agammaglobulinemia (D80-84)

5.23

5.97

1.5

1.3

—

Other viral hepatitis

317

1.98

5.94

1.3

1.2

—

Hypertension, Pulmonary Arterial

6.60

5.92

1.4

1.5

—

Open wound of lower leg

101

600

1.69

5.92

1.2

1.3

—

Small fibre neuropathy

2.99

5.87

1.2

—

Bacterial, viral and other infectious agents

461

1.80

5.86

1.3

1.2

—

Macular pucker

318

1.96

5.85

1.1

—

Alport

15.16

5.82

1.0

1.7

—

Nail disorders

348

1.91

5.78

1.1

1.2

—

N06DA Anticholinesterases

478

0.36

5.78

1.0

1.1

—

Use of anticholinesterases

478

0.36

5.78

1.0

1.1

—

Irregular menses

382

2317

1.31

5.77

1.3

—

Special screening examination for other diseases and disorders

334

1.93

5.74

1.4

1.3

—

Ulcerative ileocolitis

181

2.30

5.74

1.1

1.2

—

Drug-induced hypoglycaemia without coma

3.77

5.68

1.1

1.2

—

Malignant cancer of tonsil and base of tongue

3.76

5.67

1.1

—

Lupus nephritis

9.04

5.67

1.0

1.5

—

Unspecific neurodegenerative disorder

577

0.46

5.66

1.0

1.1

—

Malignant neoplasm of head and neck

163

2.35

5.64

1.1

—

Amyloidosis

3.59

5.63

1.5

1.1

—

Prurigo nodularis

3.33

5.61

1.1

1.2

—

Infarction of spleen

10.40

5.59

1.1

1.3

—

Artificial opening status

2.82

5.57

1.4

1.2

—

Fracture of foot, except ankle

185

1280

1.45

5.56

1.2

1.3

—

Infection due to other mycobacteria

5.95

5.55

1.2

—

Bacterial, viral and other infectious agents

418

1.81

5.54

1.3

1.2

—

Primary hyperparathyroidism

263

2.03

5.51

1.2

—

Polyuria

110

682

1.62

5.48

1.2

—

Other nutritional deficiencies

482

3624

1.26

5.46

1.2

—

Lung diseases due to external agents

362

1.86

5.44

1.2

—

Type 1 diabetes, strict (exclude DM2)

568

1.68

5.43

1.2

1.3

—

Acute pharyngitis

142

932

1.52

5.35

1.3

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

211

1507

1.41

5.33

1.2

—

Obsessive-compulsive disorder

424

1.79

5.31

1.2

1.3

—

Female infertility, associated with anovulation

104

644

1.63

5.28

1.2

1.3

—

Melanocytic naevi of lower limb, including hip

175

2.26

5.28

1.3

—

Crohn disease

110

690

1.61

5.27

1.2

1.3

—

Soft tissue disorders

781

3357

1.20

5.26

1.2

—

Kela-code for severe mental illness

131

1971

0.66

5.26

1.1

1.2

—

Rosacea

462

1.74

5.25

1.2

—

Cryoglobulinemia

15.16

5.24

1.3

1.5

—

Cystic fibrosis, other manifestations/unspecified

15.12

5.24

1.1

1.5

—

Urticaria and erythema

261

1936

1.35

5.23

1.3

1.2

—

Malignant neoplasm of other connective and soft tissue

3.68

5.22

1.6

1.2

—

Other systemic involvement of connective tissue

145

969

1.50

5.21

1.2

—

Other and unspecified glaucoma

138

2.41

5.21

1.1

1.2

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

241

1747

1.37

5.21

1.2

—

Malignant neoplasm of kidney, except renal pelvis

157

2.31

5.18

1.1

—

Cystic fibrosis

14.43

5.18

1.1

1.5

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

205

1465

1.40

5.18

1.2

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

435

1.76

5.18

1.5

1.3

—

Hypothyroidism, strict autoimmune

476

2499

1.26

5.17

1.2

1.3

—

Hyperhidrosis

103

2.65

5.17

1.1

1.3

—

Adverse effects, not elsewhere classified

153

1037

1.48

5.16

1.2

1.3

—

Retained placenta and membranes, without haemorrhage

472

1.73

5.15

1.3

—

Type of accident

192

1360

1.42

5.11

1.2

—

Viral hepatitis

349

1.85

5.11

1.2

—

Stroke, excluding SAH

270

1465

1.35

5.10

1.2

—

Alcohol use disorder, Swedish definition

347

2466

1.29

5.04

1.1

1.2

—

Nonsuppurative otitis media

229

1447

1.38

5.02

1.2

1.3

—

Abnormal findings on diagnostic imaging of central nervous system

179

2.20

5.01

1.4

1.2

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

462

1.73

4.99

1.2

1.3

—

374

2649

1.28

4.98

1.1

1.2

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

187

2.17

4.93

1.6

1.2

—

Abnormal findings in nipple discharge synovial fluid wound secretions

3.29

4.93

1.2

1.3

—

Other meningitis

3.28

4.92

1.3

—

Cyst of kidney

174

2.20

4.91

1.1

1.2

—

Other diseases of gallbladder

112

2.52

4.88

1.1

1.2

—

Familial hypercholesterolemia

332

1.84

4.88

1.1

1.2

—

Postmenopausal osteoporosis with pathological fracture

2.79

4.88

1.1

—

Other disorders of breast and lactation associated with childbirth

125

2.46

4.86

1.4

—

Chronic hepatitis NAS

4.32

4.86

1.2

1.3

—

Duodenal ulcer

228

2.03

4.84

1.1

1.2

—

Ulcerative enterocolitis

131

2.40

4.84

1.1

1.3

—

Other, unspecified and serous retinal detachments

2.85

4.83

1.1

1.2

—

Neuromuscular dysfunction of bladder

284

1.91

4.82

1.1

1.2

—

Recurrent aphthous stomatitis , including avohilmo

620

1.61

4.81

1.2

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

2.94

4.80

1.1

1.4

—

Viral infections of the central nervous system

313

1.87

4.80

1.2

—

Intracranial and intraspinal abscess and granuloma

4.54

4.79

1.1

1.2

—

Adult respiratory distress syndrome

4.52

4.78

1.3

—

Basal cell carcinoma, including avohilmo

155

729

1.47

4.77

1.1

—

Cholelithiasis, broad definition with cholecystitis

497

2711

1.24

4.76

1.2

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

341

2586

1.28

4.76

1.2

—

Conjunctivitis

539

3692

1.22

4.76

1.2

—

Coronary artery bypass grafting

423

1.64

4.75

1.1

1.2

—

Malignant neoplasm of urinary organs

170

2.19

4.74

1.1

—

Retention of urine

154

868

1.46

4.74

1.1

1.2

—

Pneumonia derived septicemia

120

2.45

4.73

1.2

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

102

2.58

4.73

1.2

1.3

—

Other diseases of oesophagus

244

1.98

4.72

1.1

1.2

—

Cerebral aneurysm, nonruptured

265

1.94

4.72

1.2

—

Other inflammation of eyelid

500

1.67

4.71

1.2

—

Other abnormal findings of blood chemistry

158

2.24

4.70

1.3

—

Polyarteritis nodosa

7.38

4.69

1.3

1.4

—

Abnormality of white blood cells, not elsewhere classified

5.17

4.68

1.5

1.4

—

Toxic encephalopathy

15.22

4.67

1.0

1.6

—

Obesity related asthma

202

1468

1.38

4.67

1.2

—

Other bacterial agents as the cause of diseases classified to other chapters

3.57

4.65

1.1

1.3

—

Use of donepezil

272

0.28

4.64

1.0

1.1

—

Other disorders of adrenal gland

159

2.22

4.64

1.1

1.3

—

Basal cell carcinoma

146

686

1.48

4.63

1.1

—

Cytomegaloviral hepatitis

10.76

4.61

1.0

1.4

—

389

2726

1.26

4.59

1.1

1.2

—

Monocytic leukaemia

10.60

4.59

2.0

1.3

—

Malignant melanoma of skin

233

1.98

4.58

1.2

—

Injuries to unspecified part of trunk, limb or body region

406

1.74

4.58

1.1

1.2

—

Lack of expected normal physiological development

2.53

4.57

1.4

1.3

—

Other and unspecified acne

2.79

4.56

1.2

1.3

—

Crohn's disease of large intestine

241

1.97

4.55

1.2

—

Episodal and paroxysmal disorders

805

3479

1.18

4.53

1.2

—

Other external causes of accidental injury

617

2563

1.21

4.52

1.2

1.3

—

Dentofacial anomalies [including malocclusion]

525

3468

1.22

4.51

1.3

1.2

—

Short stature, not elsewhere classified

137

2.28

4.49

1.4

—

Corneal ulcer

124

831

1.50

4.48

1.2

—

Intrahepatic Cholestasis of Pregnancy (ICP)

417

1.72

4.47

1.2

1.3

—

Pain associated with micturition

409

1.72

4.46

1.2

—

Macular cyst

2.96

4.46

1.1

1.2

—

Liver disorders in diseases classified elsewhere

8.07

4.45

1.0

1.4

—

Absence of one kidney

8.02

4.44

1.0

1.6

—

Xerosis cutis

4.14

4.43

1.1

1.2

—

Other follicular disorders

366

1.76

4.42

1.2

1.3

—

Embedded and impacted teeth

293

1868

1.30

4.41

1.3

—

Congenital vesicoureteral reflux

3.49

4.40

1.6

1.3

—

Gangrene, not elsewhere classified

7.70

4.38

1.0

1.2

—

Acne

113

746

1.52

4.38

1.2

1.3

—

Crohn's disease (strict) with PSC

12.81

4.38

1.3

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Toxoplasma gondii IgM Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS